The association of abnormal α-fetoprotein and adverse pregnancy outcome: Does increased fetal surveillance affect pregnancy outcome?

作者: Glenn Huerta-Enochian , Vern Katz , Stephen Erfurth

DOI: 10.1067/MOB.2001.114864

关键词:

摘要: Abstract Objective: Our purpose was to investigate whether adverse outcomes associated with elevated maternal serum α-fetoprotein levels may be prevented by intensive antenatal monitoring. Study Design: Records of patients values ≥2.0 multiples the median between 1995 and 1999 were reviewed. Pregnancy histories analyzed determine monitoring (twice-weekly nonstress tests determinations amniotic fluid index) would have detected when routine obstetric care missed them. Women elevations explained multiple gestations, structural abnormalities, or a fetal death excluded. Results: The study enrolled 136 patients. Twenty-three excluded because chromosomal for lack available follow-up. Seventy-eight had no perinatal complications, but 12 these underwent heightened surveillance. One subjected an induction labor. Thirty-five pregnancies complications (21 preterm labor, 7 pregnancy-induced hypertension, 6 growth restriction oligohydramnios, 1 abruptio placentae, vasa previa). Of 35 pregnancies, 22 followed up 13 Heightened surveillance did not achieve earlier improved detection in this group. These results suggest that pregnancy management is adequate strategy providing pregnant unexplained levels. Adverse undetectable even management. Conclusion: Increased risks delivery, intrauterine restriction, death, placentae are However, our study, acceptable method detecting they detectable. (Am J Obstet Gynecol 2001;184:1549-55.)

参考文章(19)
A M Vintzileos, W Cusick, W A Campbell, M McMahon, S M Albini, J F Rodis, Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation Journal of Reproductive Medicine. ,vol. 41, pp. 327- 332 ,(1996)
M Van Rijn, YT Van Der Schouw, AM Hagenaars, GHA Visser, GCML Christiaens, Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening. Obstetrics & Gynecology. ,vol. 94, pp. 929- 934 ,(1999) , 10.1016/S0029-7844(99)00467-6
R J Montgomery, P A Morland, M R Jenner, H C Soltan, T A Doran, R J Benzie, G Wielgosz, L C Allen, G H Valentine, P Y Wong, Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project Canadian Medical Association Journal. ,vol. 137, pp. 285- 293 ,(1987)
Carolyn M. Salafia, Lester Silberman, Nilo E. Herrera, Maurice J. Mahoney, Placental pathology at term associated with elevated midtrimester maternal serum α-fetoprotein concentration American Journal of Obstetrics and Gynecology. ,vol. 158, pp. 1064- 1066 ,(1988) , 10.1016/0002-9378(88)90220-7
D.J.H. Brock, Lilias Barron, Paddy Jelen, Muriel Watt, J.B. Scrimgeour, MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENTS AS AN EARLY INDICATOR OF LOW BIRTH-WEIGHT The Lancet. ,vol. 310, pp. 267- 268 ,(1977) , 10.1016/S0140-6736(77)90952-7
A. Ghosh, M. H. Y. Tang, D. Taig. Nie, H. K. Ma, Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects. Prenatal Diagnosis. ,vol. 6, pp. 83- 87 ,(1986) , 10.1002/PD.1970060202
P. Jones, A. McNay, W. Walker, Association between Foeto-maternal Bleeding and Hypertension in Pregnancy BMJ. ,vol. 3, pp. 738- 742 ,(1969) , 10.1136/BMJ.3.5673.738
Yuval Yaron, Michele Cherry, Ralph L. Kramer, Joseph E. O’Brien, Mordechai Hallak, Mark P. Johnson, Mark I. Evans, Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome American Journal of Obstetrics and Gynecology. ,vol. 181, pp. 968- 974 ,(1999) , 10.1016/S0002-9378(99)70334-0
C. G. Bergstrand, Birgit Czar, Demonstration of a New Protein Fraction in Serum from the Human Fetus Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 8, pp. 174- 174 ,(1956) , 10.3109/00365515609049266